VIB-RUG Department of Molecular Biomedical Research |
|
Our mission is to develop technology based on the creation and use of molecules modifying the immune system, in order to investigate new opportunities in immunotherapy. Our main project involves the evaluation of an improved manifold for the creation of multivalent, multispecific or multifunctional antibody derivatives, in order to obtain recombinant antibody-based anti-cancer reagents. The ultimate goal is to evaluate new opportunities to immunotherapeutic approaches using recombinant antibody derivatives. We also develop technology to further improve the chance on successful heterologous expression in E. coli, especially cytokines.
Here you will find some background information about developed technology
These pages are best viewed with MS Internet Explorer 5 or higher Welcome visitor Site update 25/08/2003 |
|
© 2002 Webmaster |